According to the report “Cardiovascular Therapeutic Drugs Market“, published by Market Data Forecast, the global market is projected to reach USD 141.38 Billion by 2021, at a CAGR of 2.2% from 2016 to 2021.
Cardiovascular therapeutic drugs are the prescribed drugs and medicines for the diseases that are related to the structure and function of the heart and blood vessels. The past few decades have witnessed significant success in the development of highly effective drug therapies for common cardiovascular disease. The widespread use of these therapies along with the rising cardiovascular disease accounts for the increasing market for cardiovascular therapeutics.
While cardiovascular disorders remains the major cause of morbidity and mortality in the world, the therapeutic drugs market is driven by the increasing aging population, epidemic of general medical problems like obesity & diabetes and growth in the per capita medical spending. However, shrinking target population, rising cost of drug development are the major restraint faced by the market. And, despite the wide prevalence of the cardiovascular diseases, pipelines for drug development products have been stagnant for variety of reasons.
Global Cardiovascular therapeutic drugs market is segmented by type of disease, drug class and region.
- Cardiac arrhythmias
- Myocardial infarction
- acute coronary syndrome
- Peripheral artery disease
- Coronary artery disease
- Other Cardiovascular diseases
2.By Drug Class:
- combination drug classes
- North America
- Latin America
- Middle-East & Africa
Some of the major companies leading in the industry includes Bayer, Johnson & Johnson, AstraZeneca, Bristol-Myers Squibb, Novartis, Merck, Takeda, Sanofi, Pfizer and boehringer ingelheim.
About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Market Data Forecast, Inc.
+1-888-702-9626 (U.S. TOLL-FREE)